Thomas Metz
11Patents
6h-index
20Co-inventors
62Inventor score
Filing activity: Sep 7, 1995 → May 2, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7220750B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | Chemistry; Metallurgy | 50 | Expired |
| US6972288B1 | 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases | Chemistry; Metallurgy | 38 | Expired |
| US5707989A | Pyrimido5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation | Chemistry; Metallurgy | 24 | Expired |
| US5977102A | Pyrimido [5, 4-d] pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation | Human Necessities | 14 | Expired |
| US5821240A | Pyrimido5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof | Human Necessities | 11 | Expired |
| US7923253B2 | Method for identifying type I diabetes mellitus in humans | Physics | 10 | Active |
| US8722694B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | Chemistry; Metallurgy | 1 | Active |
| US8748352B2 | Peptide and protein biomarkers for type 1 diabetes mellitus | Physics | 0 | Active |
| US8691506B2 | Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds | Physics | 0 | Active |
| US8673644B2 | Serum markers for type II diabetes mellitus | Physics | 0 | Active |
| US9429569B2 | Peptide and protein biomarkers for type 1 diabetes mellitus | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.